Similar articles for PMID: 29486991

Year	Number of Results
1993	1
1996	1
2000	1
2002	3
2003	1
2005	6
2006	3
2007	1
2008	4
2009	2
2010	3
2012	4
2013	11
2014	10
2015	9
2016	5
2017	6
2018	5
2019	12
2020	17
2021	14
2022	8
2023	3
2024	0

1

Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.

Barrington DA, Champion ML, Boitano TKL, Walters-Haygood CL, Farmer MB, Alvarez RD, Estes JM, Leath CA 3rd. Barrington DA, et al. Gynecol Oncol. 2018 May;149(2):337-340. doi: 10.1016/j.ygyno.2018.02.014. Epub 2018 Mar 2. Gynecol Oncol. 2018. PMID: 29486991 Free PMC article.

2

Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.

Boitano TKL, Barrington DA, Batra S, McGwin G Jr, Turner TB, Farmer MB, Brown AM, Straughn MJ Jr, Leath CA 3rd. Boitano TKL, et al. Gynecol Oncol. 2019 Aug;154(2):379-382. doi: 10.1016/j.ygyno.2019.05.031. Epub 2019 Jun 10. Gynecol Oncol. 2019. PMID: 31196574 Free PMC article.

3

Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.

Pal T, Bonner D, Kim J, Monteiro AN, Kessler L, Royer R, Narod SA, Vadaparampil ST. Pal T, et al. Breast J. 2013 Mar-Apr;19(2):189-92. doi: 10.1111/tbj.12083. Epub 2013 Jan 16. Breast J. 2013. PMID: 23320992

4

Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.

Lee SS, Karpel HC, Oh C, Smith J, Pothuri B. Lee SS, et al. Gynecol Oncol. 2023 Mar;170:234-240. doi: 10.1016/j.ygyno.2022.12.012. Epub 2023 Jan 30. Gynecol Oncol. 2023. PMID: 36724586

5

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.

Choi YH, Terry MB, Daly MB, MacInnis RJ, Hopper JL, Colonna S, Buys SS, Andrulis IL, John EM, Kurian AW, Briollais L. Choi YH, et al. JAMA Oncol. 2021 Apr 1;7(4):585-592. doi: 10.1001/jamaoncol.2020.7995. JAMA Oncol. 2021. PMID: 33630024 Free PMC article.

6

Testing for hereditary breast and ovarian cancer in the southeastern United States.

Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart JD. Miron A, et al. Ann Surg. 2000 May;231(5):624-34. doi: 10.1097/00000658-200005000-00002. Ann Surg. 2000. PMID: 10767783 Free PMC article. Clinical Trial.

7

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. Nanda R, et al. JAMA. 2005 Oct 19;294(15):1925-33. doi: 10.1001/jama.294.15.1925. JAMA. 2005. PMID: 16234499

8

The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.

Gornjec A, Merlo S, Novakovic S, Stegel V, Gazic B, Perhavec A, Blatnik A, Krajc M. Gornjec A, et al. Radiol Oncol. 2020 May 28;54(2):180-186. doi: 10.2478/raon-2020-0020. Radiol Oncol. 2020. PMID: 32463390 Free PMC article.

9

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, Mai PL, Loud J, Rodriguez G, Basil J, Boggess J, Schwartz PE, Kelley JL, Wakeley KE, Minasian L, Skates S. Greene MH, et al. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):594-604. doi: 10.1158/1055-9965.EPI-07-2703. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349277 Free PMC article.

10

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987. JAMA. 2019. PMID: 31429903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year